CRP and cardiovascular disorder: The recent 2025 statement from the American College of Cardiology (ACC) on inflammation and cardiovascular disease recommends hs-CRP measurement as part of CVD primary prevention, reinforcing the clinical relevance of inflammation as a modifiable risk factor (62).